ストックスクリーナーアプリを入手
4.25
5.99%
0.24
アフターアワーズ：
4.30
0.05
+1.18%
前日終値:
$4.01
開ける：
$4.05
24時間の取引高:
330.52K
Relative Volume:
0.12
時価総額：
$53.72M
収益：
-
当期純損益:
$-30.54M
株価収益率:
-2.7419
EPS:
-1.55
ネットキャッシュフロー:
$-18.30M
1週間 パフォーマンス:
+0.95%
1か月 パフォーマンス:
-15.17%
6か月 パフォーマンス:
+699.47%
1年 パフォーマンス:
+1,137%
1日の値動き範囲:
$3.97
$4.265
1週間の範囲:
$3.97
$4.43
52週間の値動き範囲:
$0.202
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
名前
Unicycive Therapeutics Inc
セクター
電話
650-384-0642
住所
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.25 | 51.20M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-21 | 開始されました | Guggenheim | Buy |
| 2024-04-04 | 開始されました | Piper Sandler | Overweight |
Unicycive Therapeutics Inc (UNCY) 最新ニュース
Real time pattern detection on Unicycive Therapeutics Inc. stockLong Term Equity Screener with Safety Metrics - Newser
Is it time to cut losses on Unicycive Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser
Does Unicycive Therapeutics Inc. fit your quant trading modelEntry Timing with Downside Risk Analysis - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - WV News
Does Unicycive Therapeutics Inc. qualify in momentum factor screeningFree High Growth Low Risk Stock Selection - Newser
How to integrate Unicycive Therapeutics Inc. into portfolio analysis toolsFree Scalable Portfolio Growth Suggestions - Newser
Is a relief rally coming for Unicycive Therapeutics Inc. holdersBreakout Watcher with Entry and Exit Alerts - Newser
Technical signs of recovery in Unicycive Therapeutics Inc.Free Real Profit Trade Plan Suggestions - Newser
Will breakout in Unicycive Therapeutics Inc. lead to full recoveryStock Price Prediction Using AI Tools - Newser
Is Unicycive Therapeutics Inc. impacted by rising ratesFree Screener for Explosive Stocks - thegnnews.com
Using Python tools to backtest Unicycive Therapeutics Inc. strategiesFree Exit Ready Momentum Stock Watchlist - Newser
Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionAnnual Market Behavior and Sector Summary - Newser
What high frequency data says about Unicycive Therapeutics Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
Institutional scanner results for Unicycive Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Real time social sentiment graph for Unicycive Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Connect - ACCESS Newswire
Momentum divergence signals in Unicycive Therapeutics Inc. chartRSI and MACD Signal Summary with Trends - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
What drives Unicycive Therapeutics Inc. stock priceNavigate the market with precision tools - Jammu Links News
Unicycive Therapeutics Inc. Stock Analysis and ForecastBuild wealth faster with expert stock picks - Jammu Links News
What are Unicycive Therapeutics Inc. company’s key revenue driversFind the best stocks for sustainable growth - Jammu Links News
Technical analysis overview for Unicycive Therapeutics Inc. stockPrice Action Summary and Entry Strategy Guide - Newser
What makes Unicycive Therapeutics Inc. stock price move sharplyOutstanding trading profits - Jammu Links News
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Up 1,211.2% in July - Defense World
Is Unicycive Therapeutics Inc. a growth stock or a value stockFree Popular Stock Recommendations - Jammu Links News
Does Unicycive Therapeutics Inc. stock perform well during market downturnsExceptional financial outcomes - Jammu Links News
What are the technical indicators suggesting about Unicycive Therapeutics Inc.Jaw-dropping returns - Jammu Links News
How many analysts rate Unicycive Therapeutics Inc. as a “Buy”High-profit capital plays - Jammu Links News
When is Unicycive Therapeutics Inc. stock expected to show significant growthExceptional gains - Jammu Links News
Unicycive Therapeutics Inc. stock trendline breakdownWeekly Stock Picks with Trend Confidence - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Quantitative breakdown of Unicycive Therapeutics Inc. recent moveDaily Investment Ideas with Market Insight - Newser
Unicycive Therapeutics Inc. stock trend forecastDaily Upside Movement Prediction With Data - Newser
Why is Unicycive Therapeutics Inc. stock attracting strong analyst attentionWealth Building Insights With Low Risk - jammulinksnews.com
Unicycive Therapeutics Inc (UNCY) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):